title: Slowing progression of chronic kidney disease.
abstract: Early identification of chronic kidney disease (CKD) provides an opportunity to implement therapies to improve kidney function and slow progression. The goal of this article is to review established and developing clinical therapies directed at slowing progression. The importance of controlling blood pressure will be discussed along with the target blood pressure that should be achieved in CKD patients. Therapy directed at inhibiting the renin-angiotensin-aldosterone system remains the mainstay of treatment with single-agent inhibition of this system being as good as dual blockade with fewer adverse effects. Other therapies that may be used include correction of metabolic acidosis, dietary protein restriction, and new models for delivering care to patients with CKD. Emerging therapies targeting endothelin, uric acid, kidney fibrosis, and oxidant stress hold promise for the future.
authors.affiliation: Division of Renal Diseases and Hypertension, Department of Medicine, University of Minnesota Medical School , Minneapolis, Minnesota, USA.
authors.forename: Paul E
authors.initials: PE
authors.lastname: Drawz
authors.affiliation: Division of Renal Diseases and Hypertension, Department of Medicine, University of Minnesota Medical School , Minneapolis, Minnesota, USA.
authors.forename: Mark E
authors.initials: ME
authors.lastname: Rosenberg
keywords: blood pressure target; chronic kidney disease; endothelin; progression; renin–angiotensin–aldosterone